Philippe Tuppin, MD, PhD

Department of Pathologies and Patients, Caisse Nationale d’Assurance Maladie, Paris, France

JCP
Acceptability of Second-Line Antidepressant Medications
Original Research

October 17, 2022

Second-line antidepressant options were ranked according to acceptability (efficacy and tolerability), using data from the French health system.
Charles Ouazana-Vedrines, Thomas Lesuffleur, Pierre Denis, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe